Study Evaluating Renal Cell Carcinoma Risk Factors

Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma

This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patients naïve to renal cell carcinoma (RCC) treatment.

invitation to volunteer

Inclusion Criteria:

• Treatment naïve patients with proven advanced RCC will be evaluated. (Except surgery or radiotherapy)
• =18 years, any gender.
• Patients with advanced Renal Cell Carcinoma and treatment naïve.

Exclusion Criteria:

• Patients who have already initiated any kind of specific therapy for the treatment of RCC.2.
• Patients with other neoplasias different from RCC (current or past).